...
首页> 外文期刊>Annals of clinical biochemistry. >Validation of an automated ultraperformance liquid chromatography IgG N-glycan analytical method applicable to classical galactosaemia
【24h】

Validation of an automated ultraperformance liquid chromatography IgG N-glycan analytical method applicable to classical galactosaemia

机译:验证自动超细型液相色谱IgG N-聚糖的分析方法,适用于古典半乳糖瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Classical galactosaemia (OMIM #230400) is a rare disorder of carbohydrate metabolism caused by deficiency of the galactose-1-phosphate uridyltransferase enzyme. The pathophysiology of the long-term complications, mainly cognitive, neurological and female fertility problems, remains poorly understood. Current clinical methods of biochemical monitoring lack precision and individualization with an identified need for improved biomarkers for this condition. Methods: We report the development and detailed validation of an automated ultraperformance liquid chromatography N-glycan analytical method of high peak resolution applied to galactose incorporation into human serum IgG. Samples are prepared on 96-well plates and the workflow features rapid glycoprotein denaturation, enzymatic glycan release, glycan purification on solid-supported hydrazide, fluorescent labelling and post-labelling clean-up with solid-phase extraction. Results: This method is shown to be accurate and precise with repeatability (cumulative coefficients of variation) of 2.0 and 8.5%, respectively, for G0/G1 and G0/G2 ratios. Both serum and processed N-glycan samples were found to be stable at room temperature and in freeze-thaw experiments. Conclusions: This high-throughput method of IgG galactose incorporation is robust, affordable and simple. This method is validated with the potential to apply as a biomarker for treatment outcomes for galactosaemia.
机译:背景:古典半乳糖瘤(OMIM#230400)是一种罕见的碳水化合物代谢缺乏缺乏半乳糖-1-磷酸脲基丙基转移酶酶。长期并发症的病理生理学,主要是认知,神经系统生育问题,仍然清晰。目前的生化监测临床方法缺乏精度和个体化,鉴定需要改进的生物标志物进行这种情况。方法:我们报道了一种自动超细液相色谱法的开发和详细验证,高峰值分辨率的N-聚糖分析方法应用于人血清IgG中的半乳糖掺入。样品在96孔板上制备,工作流程具有快速糖蛋白变性,酶聚糖释放,甘油纯化在固体负载的酰肼,荧光标记和标记后的固相萃取清洁。结果:该方法分别为2.0 / G1和G0 / G2比分别为2.0和8.5%的重复性(累积变异系数)精确且精确。发现血清和加工的N-聚糖样品在室温和冻融实验中被发现稳定。结论:这种IgG半乳糖掺入的高通量方法是坚固的,实惠且简单。该方法验证了施加作为生物标志物的潜力,用于治疗半乳糖瘤的治疗结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号